Results for:(111 found)
May 5, 2014 2:19PM on InvestingBy MSN Money Partner

As the company prepares for a breathtakingly large IPO, the executive chairman looms large in its operations.

Apr 30, 2014 12:08PM on Top StocksBy MSN Money Partner

The company's unusual step ensures it has the money to buy something big. It's paying a steep price, though.

Apr 24, 2014 2:20PM on Top StocksBy MSN Money Partner

Delivering packages will give the company, stung by shipping delays last Christmas, more control over the shopping experience.

Apr 23, 2014 12:58PM on Top StocksBy InvestorPlace

Wall Street is getting more selective and demanding profits from this hyped-up sector.

Apr 17, 2014 3:36PM on Top StocksBy MSN Money Partner

The company, headed for an IPO later this year, is worth as much as 10 Tesla Motors combined, says Bernstein's Carlos Kirjner.

Apr 14, 2014 2:33PM on Top StocksBy InvestorPlace

The company could become a powerful force in online payments, rivaling Western Union and Moneygram.

Apr 9, 2014 2:07PM on Top StocksBy MSN Money Partner

More stockholders are campaigning against public companies. A new study reveals how treacherous these situations can be.

Tags: EBAYJCP
Mar 26, 2014 12:24PM on InvestingBy MSN Money Partner

The ticket reseller is singing the blues after its attempt at price transparency backfires. 'People are not that smart,' one rival says.

Tags: EBAY

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

TOP STOCKS

This stock is up nearly 300%

Puma Biotechnology shares soar after it says it wants to file for marketing approval of an experimental breast cancer drug.

More

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More